PARIS — The EU Joint Programme – Neurodegenerative Illness Analysis (JPND) initiative1 has launched its updated international Analysis and Innovation Method (RIS), to deliver a unified framework for the assistance of planet class study into neurodegenerative ailments.

Neurodegenerative ailments are 1 of the world’s top healthcare and societal challenges and there are now anticipated to be 50 million persons worldwide suffering from Alzheimer’s illness and associated issues. Globally, these numbers show no indicators of abating, and it is estimated that by 2050 in Europe alone, the total direct and informal care expenses for Alzheimer’s and Parkinson’s illness will exceed €350 billion annually.two

JPND is the 1st and biggest collaborative study initiative established to tackle the expanding challenge posed by neurodegenerative ailments. JPND’s ultimate objective is to accelerate the discovery of a remedy and to allow early diagnosis for early personalised therapies. In the meantime, it is important to implement options that can alleviate, albeit partially, the plight of households and the financial burden brought about by the growing prevalence of this illness in our ageing populations. Therefore apart from simple study, the scientific endeavour issues also translational and clinical, and social care and wellness solutions researches.

Today’s release of the Analysis and Innovation Method (RIS) updates the typical vision of 30 JPND member nations. It renews the technique that was 1st published in 2012, to tackle the significant societal challenge of neurodegenerative ailments.

Dr Barbara Kerstiëns, Head of the unit accountable for Non-Communicable Illnesses and the Challenge of Healthful Ageing in the European Commissions’ Directorate-Basic for Analysis &amp Innovation says: “The European Commission recognises that JPND has been instrumental in addressing Neurodegenerative Illnesses study by aligning and coordinating national efforts amongst Member States and other nations, minimizing fragmentation and duplication in study and all round growing the effectiveness and effect of study in this field.

JPND’s ambitious new RIS invites multidisciplinary and cross-sectoral collaboration as nicely as engagement with sufferers, their households and carers. Its 5 scientific priorities cover the complete spectrum of unmet requires – the understanding gap, the prevention gap, the early diagnosis and illness management gap, as nicely as the expanding socio-financial challenges of caring for and assisting persons faced with these ailments. The technique requires vital things relating to neurodegenerative ailments care into account, such as comorbidities, sex and gender variations, the part of ageing and the complicated ethical problems. Additionally, the RIS suggestions are in line with the Commission’s priorities in fostering revolutionary partnerships, taking benefit of the most up-to-date advances in digital technologies, like artificial intelligence, advertising an Open Access method and translating study findings into evidenced-primarily based public wellness policies and, in the end, improved wellness and social care.”

Professor Philippe Amouyel, University of Lille (France) and Chair of the JPND Management Board says: “The challenge is to tackle neurodegeneration, and in specific, Alzheimer’s illness by way of an unprecedented collaboration at the European level and beyond. The ultimate objective is to facilitate the cooperation of researchers, to decrease fragmentation, to protect against unnecessary doubling of efforts and to pool and organise sources on a voluntary basis for the advantage of the populations. Our RIS types the basis for present and future JPND initiatives, as nicely as a basic reference point for the national and strategic plans. It supplies a international and typical framework for future investment that addresses how nations can proficiently enhance prevention, diagnosis, remedy and patient care.

JPND Scientific Advisory Board Chair, Professor Thomas Gasser says: “Considering that the publication of our 1st RIS in 2012, there have been significant advances, each scientific and technological, that have shaped the renewed RIS. Information science, like artificial intelligence-driven approaches of information analyses, has transformed a lot of study places, and this is now reflected in the updated Method. An additional vital concern reflected in the renewed Method is the growing awareness that the inclusion of things like financial and cultural variations, gender problems and public and patient involvement will have to clearly play a far more prominent part.”

Note to Editors:

JPND is committed to aligning and creating upon national programmes to boost effect and effectiveness of study and to recognize typical ambitions that would advantage from joint action.

  • The origins and progression of neurodegenerative ailments
  • Illness mechanisms and models
  • Diagnosis, prognosis and illness definitions
  • Creating therapies, preventive methods and interventions
  • Wellness and social care

JPND receives assistance from the European Commission.

JPND is functioning to implement the above ambitions by way of:

  • Creating supportive infrastructure and platforms by way of harmonisation of information and supplies and promotion of an open access method to the sharing of information and sources
  • Partnering with sector and healthcare providers and advertising innovation inside a multi-companion international funding framework
  • Creating higher interaction with regulators to integrate patient requires
  • Linking worldwide study efforts in neurodegenerative illness study
  • Utilising sources and infrastructure outdoors of Europe and improved connecting international patient public involvement (PPI)
  • Creating capacity by way of strengthening particular neurodegenerative illness study places and establishing networks across and in between disciplines and researchers
  • Creating an proof-led educational method to embed a study culture across the complete spectrum of wellness, social and palliative care
  • Strengthening the connection to policy makers
  • Making certain productive communication of the study agenda and engaging with a wide variety of sectors and stakeholders

For far more information and facts about the Analysis and Innovation Method, click right here.


1 Joint Programming is a collaborative method supported by the European Commission in which nations define a typical vision and a strategic study agenda, in order to address significant societal challenges which are beyond the scale of any national study programme. The Joint Programme on Neurodegenerative Illness Analysis (JPND) was established as the pilot for this new variety of coordinated method to study.
two Maresova et al.,Alzheimer’s and Parkinson’s Illnesses: Anticipated Financial Effect on Europe-A Contact for a Uniform European Method, 2016, Journal of Alzheimer’s Illness, 54(three):1123-1133.



Name: Karin YEO
Mobile: +33 1 44 23 64 78
E mail: [email protected]
Twitter: @JPNDEurope